Natalie C. Holles - Net Worth and Insider Trading
Natalie C. Holles Net Worth
The estimated net worth of Natalie C. Holles is at least $14 Million dollars as of 2024-05-03. Natalie C. Holles is the CEO of Third Harmonic Bio Inc and owns about 1,218,836 shares of Third Harmonic Bio Inc (THRD) stock worth over $14 Million. Details can be seen in Natalie C. Holles's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Natalie C. Holles has not made any transactions after 2024-04-11 and currently still holds the listed stock(s).
Transaction Summary of Natalie C. Holles
Natalie C. Holles Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Natalie C. Holles owns 5 companies in total, including Rubius Therapeutics Inc (RUBY) , Audentes Therapeutics Inc (BOLD) , and Allakos Inc (ALLK) among others .
Click here to see the complete history of Natalie C. Holles’s form 4 insider trades.
Insider Ownership Summary of Natalie C. Holles
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RUBY | Rubius Therapeutics Inc | 2019-03-19 | director |
BOLD | Audentes Therapeutics Inc | 2020-01-15 | President and COO |
ALLK | Allakos Inc | 2020-12-21 | director |
2021-05-26 | director | ||
2024-04-11 | director & CEO |
Natalie C. Holles Latest Holdings Summary
Natalie C. Holles currently owns a total of 1 stock. Natalie C. Holles owns 1,218,836 shares of Third Harmonic Bio Inc (THRD) as of April 11, 2024, with a value of $14 Million.
Latest Holdings of Natalie C. Holles
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
THRD | Third Harmonic Bio Inc | 2024-04-11 | 1,218,836 | 11.66 | 14,205,534 |
Holding Weightings of Natalie C. Holles
Natalie C. Holles Form 4 Trading Tracker
According to the SEC Form 4 filings, Natalie C. Holles has made a total of 1 transactions in Third Harmonic Bio Inc (THRD) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Third Harmonic Bio Inc is the sale of 13,558 shares on April 11, 2024, which brought Natalie C. Holles around $165,272.
Insider Trading History of Natalie C. Holles
- 1
Natalie C. Holles Trading Performance
Natalie C. Holles Ownership Network
Ownership Network List of Natalie C. Holles
Ownership Network Relation of Natalie C. Holles
Natalie C. Holles Owned Company Details
What does Rubius Therapeutics Inc do?
Who are the key executives at Rubius Therapeutics Inc?
Natalie C. Holles is the director of Rubius Therapeutics Inc. Other key executives at Rubius Therapeutics Inc include CEO and President Dannielle Appelhans , director & Chief Executive Officer Pablo J Cagnoni , and Chief Scientific Officer Laurence A. Turka .
Rubius Therapeutics Inc (RUBY) Insider Trades Summary
Over the past 18 months, Natalie C. Holles made no insider transaction in Rubius Therapeutics Inc (RUBY). Other recent insider transactions involving Rubius Therapeutics Inc (RUBY) include a net sale of 15,688 shares made by Pablo J Cagnoni , a net sale of 14,263 shares made by Dannielle Appelhans , and a net sale of 2,593 shares made by Laurence A. Turka .
In summary, during the past 3 months, insiders sold 0 shares of Rubius Therapeutics Inc (RUBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,544 shares of Rubius Therapeutics Inc (RUBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 32,544 shares.
Rubius Therapeutics Inc (RUBY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rubius Therapeutics Inc Insider Transactions
Natalie C. Holles Mailing Address
Above is the net worth, insider trading, and ownership report for Natalie C. Holles. You might contact Natalie C. Holles via mailing address: C/o Hyperion Therapeutics, Inc., 2000 Sierra Point Parkway, Suite 400, Brisbane Ca 94005.